Cargando…
Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?
Amyotrophic lateral sclerosis (ALS) is a fatal condition primarily characterized by the selective loss of upper and lower motor neurons. At present, the diagnosis and monitoring of ALS is based on clinical examination, electrophysiological findings, medical history, and exclusion of confounding diso...
Autores principales: | Robelin, Laura, Gonzalez De Aguilar, Jose Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060749/ https://www.ncbi.nlm.nih.gov/pubmed/24991560 http://dx.doi.org/10.1155/2014/525097 |
Ejemplares similares
-
Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019) -
Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis
por: Henriques, Alexandre, et al.
Publicado: (2015) -
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
por: Staats, Kim A., et al.
Publicado: (2022) -
The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
por: Loeffler, Jean‐Philippe, et al.
Publicado: (2016) -
Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?
por: Henriques, Alexandre, et al.
Publicado: (2011)